Novartis Agrees to Sell Entire Stake in Indian Unit to WaveRise Consortium

Swiss drugmaker Novartis announced on Friday the sale of its 70.68 percent stake in its Indian arm. The buyer is a consortium led by WaveRise Investments.

Insights:
Novartis AG announced today, February 20, 2026, that it will sell its entire 70.68% stake in its listed Indian unit to a consortium of WaveRise Investments, ChrysCapital, and Two Infinity Partners. This announced sale will result in the transfer of majority ownership of the Indian unit and will fundamentally alter the ownership structure of the pharmaceutical company, which is based in Switzerland CHCH.
The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann
The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.